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042 The Journal of Thoracic and Cardbjective: To compare the efficacy of two drain types after cardiac surgery in a
andomized controlled trial, with primary outcome measure being depth of pericar-
ial effusion 3 to 5 days after drain removal.
ethods: A prospective randomized controlled trial was conducted at two university
ospitals. A total of 199 patients undergoing first-time cardiac procedures were
andomized at surgery to receive either small-bore flexible Blake drains (19F) or
arger Portex drains (28F). Drains were removed according to the study protocol and
atients underwent echocardiography 3 to 5 days after drain removal to measure
esidual pericardial effusion.
esults: Ninety patients received Blake drains and 109 patients received Portex
rains. There were no statistically significant differences in preoperative variables
etween the groups. There was no difference in the number of drains inserted per
atient between groups (Blake 2.1  0.4 vs Portex 2.0  0.5). Mean difference in
ize of pericardial effusion between groups was 1.96 mm (95% confidence interval
0.02, 3.95 mm), which did not exceed the predefined non-inferiority margin of
0 mm. There was no significant difference in the mean maximal hourly drainage
ate between groups (Blake 94.7 mL vs Portex 123.1 mL; P  .070) or in the total
rainage rates (Blake 541 mL vs Portex 679 mL; P  .066). Although the Blake
roup had a higher percentage of patients with detectable effusion (46.3% vs 27.4%;
 .011) than the Portex group, there was no difference in need for late drainage
f pericardial effusions (1.1% vs 1.9%) or insertion of further chest drains (8.8% vs
.2%).
onclusion: The performance of small-bore Blake drains is not inferior to that of
tandard Portex drains after cardiac surgery.
ardiac surgery requires the placement of drains in the mediastinum and
sometimes in pleural cavities at the end of the surgical procedure. This is to
ensure adequate drainage of blood to prevent tamponade and also to detect
emorrhage.
The usual method of drainage is to place large-bore (28F-36F) rigid Portex tubes
Portex, Inc, Hythe, Kent, United Kingdom) in the chest before wound closure.
hese drains are effective but cause pain,1 may interfere with bypass grafts,2,3 and
ay provoke cardiac arrhythmias. Despite encouraging reports of the use of smaller
ilicone rubber Blake drains4 (Ethicon, Inc, Somerville, NJ) and then convinc
etrospective study data,5 the routine use of such drains after cardiac surgery ha
een generally accepted.
Blake drains are small (10-19F) and have a fluted design, which allows a large
urface area for drainage despite the small size. The drainage channels running
long the side of the Blake drains reduce the likelihood of tissue invagination into
he drains and hence may be less likely to interfere with coronary grafts.
iovascular Surgery ● November 2006
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A
CDA prospective randomized trial confirmed that Blake
rains are less painful than traditional large-bore drai6
ut no efficacy data are available based on a larger prospec-
ive randomized controlled trial.
Our study was designed to investigate the efficacy of the
wo drain types in a randomized controlled trial with pri-
ary outcome measure being depth of pericardial effusion
ostoperatively.
ethods
atient Population and Clinical Management
onsecutive patients undergoing elective first-time cardiac surgery
ere invited to participate in the study subject to the exclusion
riteria described below. Patient recruitment took place between
eptember 2003 and September 2004 with a total of 199 patients
reated.
Local research ethics committees from the two participating
enters approved the study and written consent was obtained from
ll patients.
Patients undergoing second-time procedures, emergency or in-
ouse urgent surgery, triple valve surgery, concomitant carotid
ndarterectomy, and those with preoperative creatinine values
reater than 180 mmol/L were excluded.
Anticoagulants were discontinued 5 days before the operation.
ntiplatelet agents were administered 6 hours after the operation
nless there was significant postoperative bleeding. Antiplatelet
gents were then commenced on day 1 after the operation. Recip-
ents of mechanical valves received warfarin on postoperative day
. Recipients of tissue valves received high-dose aspirin or war-
arin depending on individual consultant protocol.
Patients were randomly assigned to receive either Blake (19F)
r Portex (28F) drains in the theater, immediately before drain
nsertion. The protocol of the study did not specify the site of drain
lacement; individual consultants followed their standard surgical
ractice, and insertion sites, number, and location of drains were
ecorded. All consultants in the study inserted drains via the
ediastinum; there were no insertions via the lateral chest wall.
All drains were connected to a chest drain bottle with an
nderwater seal and were subject to 2.5- to 5-kPa suction from the
ime of chest closure.
Drains were removed the day after the operation if no air leak
as present and if total drainage was less than 20 mL/h for at least
hours.
chocardiographic Assessment
ransthoracic echocardiography was carried out between days 3
nd 5 after drain removal to evaluate the presence of pericardial
ffusion. Echocardiography was performed by dedicated sonogra-
hers in each center who were blinded to drain type used. The
Abbreviations and Acronyms
CIA  Confidence Interval Analysis
SAS Statistical Analysis Softwarechocardiographer used a standard form that detailed eight sites for c
The Journal of Thoraciceasurements of pericardial effusion depth. At each site three
eparate measurements were made, which were then averaged. The
argest of these averages was recorded and used for analysis.
All chest x-ray films were reviewed by a radiologist in accor-
ance with standard hospital practice, and the presence of pneu-
othoraces and pleural effusions was reported. Decisions to insert
urther chest drains or to drain pericardial effusions were made
epending on the need of the individual patient concerned.
Adverse events were recorded and monitored throughout the
uration of the trial, with regular communication between the two
enters.
tatistical Analysis
tatistical analysis was conducted with SAS (Statistical Analysis
oftware) version 8.02 software (SAS Institute, Inc, Cary, NC).
ormally distributed continuous variables were analyzed by a
tudent t test. Nonnormally distributed continuous data were an-
lyzed with a Wilcoxon-Mann-Whitney test. A logistic procedure
ith stepwise inclusion of parameters was used to identify key
actors that predicted postoperative atrial fibrillation.
rimary Outcome Measure
he study was designed as a non-inferiority test. Non-inferiority
as predefined as a difference of less than 10-mm mean pericar-
ial effusion between the two groups as determined by a calculated
5% confidence interval around the mean difference in effusions
etween the groups. The calculation of the nonparametric 95%
onfidence interval for effusion used CIA (Confidence Interval
nalysis, v2.0.0, T. Bryant, University of Southampton). This
tatistical analysis was predetermined on the basis of examination
f data from a previous study by our group.6 This illustrated 
redominance of zero effusion in postoperative patients, meaning
he data were nonparametric but the median value was invari-
bly zero. Hence median is a poor comparison measure of
rimary end point and so is mean. Our statistical analysis used
calculated 95% confidence interval around the mean differ-
nce between groups, which, given the distribution of the data,
as considered the most appropriate method of comparison.
esults
f the 199 patients treated, 109 received Portex drains and
0 received Blake drains. Preoperative or intraoperative
ariables were well matched (Table 1). Other surgical 
edures performed were as follows: isolated single valve
eplacement in 10.1% and 13% in Blake and Portex groups,
espectively; combined coronary artery bypass grafting and
ingle valve replacement in 13.5% and 6.5%, respectively;
itral valve repair in 9% and 7.4%, respectively; CABG
nd mitral repair in 2.2% and 6.5%, respectively; and dou-
le valve procedures in 5.5% and 0.9%, respectively.
If the pleural cavity was breached, drainage depended on
he size of the breach and consultant protocol. The left
leura was opened in 83.7% of the Blake patients and 89%
f the Portex patients, with left pleural drains placed in
4.4% and 48.6%, respectively. Right pleural breach oc-
urred in 34.7% (Blake) and 34.3% (Portex) with right
and Cardiovascular Surgery ● Volume 132, Number 5 1043
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A
CDleural drains placed in 15.6% and 18.3% of patients,
espectively.
Despite a trend toward higher maximal hourly drainage
ate and total drainage in the Portex group, these differences
id not reach statistical significance (Table 2).
There was no significant difference between the size of
esidual pericardial effusions between the two groups, al-
hough a higher percentage of the Blake drain group had an
chocardiographically detectable pericardial effusion
Table 2). The 95% confidence intervals describing 
rimary outcome measure of difference in effusion between
he two groups crosses zero. This illustrates that presence or
bsence of pericardial effusion is a weak comparative test
etween drain type, as it does not discriminate between an
ABLE 1. Demographic and operative characteristics of
he two patient groups
haracteristic
Blake
(n  90)
Portex
(n  109) P value
emale (%) 30.0 31.2 .83
ge 65.7 (10.5) 63.6 (8.5) .11
reop creatinine (mmol/L) 97.5 (24.9) 96.9 (22.1) .80
arsonnet score 10.4 (7.7) 8.2 (5.8) .021
ormal LV (%) 65.6 67.9 .68
ABG only (%) 59.6 65.7 .38
peration time (h) 3.3 (0.9) 3.3 (0.8) .74
PB time (min) 72 (36) 78 (36) .79
rossclamp time (min) 48 (30) 54 (30) .62
esults are expressed as percent or mean (standard deviation). LV, Left
entricle; CABG, coronary artery bypass grafting; CPB, cardiopulmonary
ypass.
ABLE 2. Drain number, duration, and drainage volumes of
he two groups
ariable
Blake
(n  90)
Portex
(n  109) P value
o. of drains per patient
Mean (SD) 2.1 (0.4) 2.0 (0.5) NS
Median (range) 2.0 (2-3) 2.0 (1-3) NS
rain duration (h) 26.4 (16.2) 25.9 (11.3) .781
otal drainage (mL) 541 (446) 679 (589) .066
ean maximal hourly
drainage (mL)
94.7 (79.8) 123.1 (130.7) .070
atients with detectable
effusion (%)
46.3 27.4 .011
ean maximal pericardial
effusion (mm)
5.1 (7.2) 3.0 (6.3) .053
ean Blake-Portex
(95% CI)
1.96 mm (0.02 to  3.95)
he primary outcome statistic is highlighted in bold type. The range is
ower than the predefined limit to determine non-inferiority. Data are
xpressed as mean (standard deviation [SD]) unless otherwise stated. NS,rot significant; CI, confidence interval.
044 The Journal of Thoracic and Cardiovascular Surgery ● Novffusion of 1 mm and one of 9 mm. This was the reason the
rimary outcome measure to define equivalence was cho-
en, and our results indeed demonstrate that the criteria for
on-inferiority of the Blake drains are satisfied.
Table 3 describes the adverse events in the study
emonstrates no differences between the two groups. The
ncidence of pleural effusion is high in both groups, but no
istinction was made between tiny, small, and moderate
ffusions. The majority of effusions noted were tiny in both
roups, as reflected by the low incidence of repeat chest
rainage procedures required.
As there was a trend toward higher atrial fibrillation rate
n the Blake group, we performed multivariate logistic re-
ression analysis to define factors predictive of postopera-
ive atrial fibrillation. The only significant factors identifi-
ble were patient age and operation other than coronary
rtery bypass graft alone. Neither drain type nor size of
ffusion was predictive of atrial fibrillation.
iscussion
afe, effective drainage of the chest after cardiac surgery is
ssential to prevent cardiac tamponade, to identify life-
hreatening hemorrhage, and to reduce the incidence of
ymptomatic pleural and pericardial effusions. Despite nu-
erous attempts in cardiac surgery toward smaller incisions
nd minimally invasive approaches, the chest drainage sys-
em has not changed for years. Use of large-bore rigid chest
ubes continues at the price of associated discomfort.1,7 A
ecent article addressed the issue of pain during drain re-
oval, concluding that analgesia during drain removal is a
hallenge.8 Correspondence published in response su-
ested that the only way to reduce patient discomfort is to
se smaller and softer drains. Blake drains fulfill this crite-
ABLE 3. Secondary outcome measures of the study pop-
lation
ariable
Blake
(n  90)
Portex
(n  109) P value
neumothorax (%) 7.8 7.4 .878
leural effusion (%) 45.6 49.1 .625
trial fibrillation (%) 48.9 38.9 .154
espiratory infection (%) 15.6 11.1 .382
esternotomy for
bleeding (%)
5.6 5.6 .979
amponade (%) 2.2 0.0 .951
eath (%) 3.3 2.8 .812
urther chest drain
insertion (%)
8.8 7.2 NS
ate drainage of
pericardial effusion (%)
1.1 1.9 NS
o statistical difference is demonstrated between groups. Data are ex-
ressed as percent. NS, Not significant.ion and have been available for a number of years. Fears
ember 2006
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A
CDver suboptimal performance seem to have prevented their
ider use.
Our study illustrates that Blake drains performed in a
on-inferior manner to larger Portex drains, with the pri-
ary outcome measure being depth of postoperative peri-
ardial effusion. The study set clear limits for the definition
f non-inferiority, which were developed on the basis of
etecting a performance difference that would change clin-
cal practice. The 95% confidence interval of the mean
ifference between groups, our predetermined primary out-
ome measure, fell well short of the 10-mm non-inferiority
imit. It also crossed zero with a maximal value of 3.95 mm,
hich is too small a difference to affect clinical practice.
ence we clearly demonstrate non-inferiority between the
rains.
This study was not designed to detect a difference in
eopening for bleeding or tamponade between the treat-
ents. To detect such a difference, a much larger number
f patients would have been required. However, our
esults of equal safety profile agree with other previously
ublished case-control studies of small and large size. In
000 Obney and associates4 reported the use Blake drai
or mediastinal drainage after cardiac surgery with no
ncreased risk of tamponade in a case series of 100
atients; they also reported less pain with the smaller
rains. Since then, a further retrospective case series has
eported adequate performance of Blake drains,5 and a
etrospective nonrandomized case-control study of 554
atients showed equal efficacy of Blake drains as com-
ared with conventional drains, but with greater patient
obility in the Blake group.9
Akowauh and colleagues6 performed a prospective ran-
omized controlled trial of Blake drains versus Portex
rains in 2002, which demonstrated less pain in the Blake
roup along with equivalent efficacy, including echocardi-
graphy of all patients. This, however, was a study of only
0 patients with 35 in each group.
Recently, Ege and associates10 have reported a large
andomized controlled trial investigating the use of Blake
rains after cardiac surgery. However, this study random-
zed patients to standard drains or standard drains plus
nfracardiac Blake drains and hence the safety of sole Blake
rain usage was not evaluated. Interestingly, Ege’s group
efined an advantage of the addition of an infracardiac
lake drain to the standard drain configuration. We did not
dentify any advantage of Blake drains over standard Portex
rains; however, our study did clearly define the non-
nferiority of the smaller drains.
In conclusion, this randomized controlled trial confirms
hat the performance of small Blake drains was similar to
hat of larger Portex drains after cardiac surgery. This con-
rms other retrospective reports and smaller randomized
ontrolled trials. As there is evidence that smaller, more
The Journal of Thoracicexible drains cause less pain than the larger alternative, on
he basis of our results it is justified to use them routinely for
ost cardiac surgical patients.
tudy Limitations
his study was designed to evaluate two different drain
ypes in the setting of everyday cardiac surgical practice.
imiting the study population to only one type of surgical
rocedure would make the results difficult to extrapolate to
ther patient groups. We believe this study achieved a
eflection of routine practice. However, by doing so, the
tudy incorporates elements of variability that are difficult
o control for. Factors such as variability in the use of bone
ax, the use of bilateral internal thoracic arteries, and
nticoagulation regimens for tissue valves may all have
mall effects on the likelihood of detectable postoperative
ericardial effusions. However, we suggest that these ef-
ects are minor and should not affect a well-defined primary
nd point.
The other main study limitation is that consultants in
harge of patient care made decisions such as when to insert
urther chest drains when they were not blinded to the drain
ype the patient received. Again, we would suggest that the
rimary end point is unlikely to have been affected by
onsultant knowledge. However, we concede the possible
ource of bias for secondary end points.
Finally, this study was designed as a test of non-
nferiority against a predefined standard. Hence it is possi-
le that there is a small performance difference between the
wo drain types in the region of 1 or 2 mm of postoperative
ericardial effusion that was not detected in this study due
o the study size. However, we would suggest that should
uch a difference exist, it is too small to have any clinical
elevance. Hence we are satisfied with our conclusion of
on-inferiority of Blake drains.
We thank the echocardiography staff at Glenfield Hospital and
orthern General Hospital for their efforts in collecting the echo-
ardiography data for this study.
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